NCT01952782View on ClinicalTrials.gov

Neuropeptides in Human Reproduction

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Hypogonadotropic Hypogonadism
Interventions
DRUG

Kisspeptin 112-121

Subjects will receive up to 10 IV doses of kisspeptin 112-121

DRUG

Naloxone

Subjects will receive one IV dose of naloxone followed by an IV infusion of naloxone.

DRUG

GnRH

Subjects will receive up to 10 doses of IV GnRH

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01952782 - Neuropeptides in Human Reproduction | Biotech Hunter | Biotech Hunter